Når Docetaxel Winthrop blev anvendt ved brystkræft som eneste behandling, var det mindst lige så effektivt som sammenligningslægemidlerne, undertiden mere effektivt.
Used on its own in breast cancer, Docetaxel Winthrop was at least as effective as, and sometimes more effective than the comparator medicines.